The filing of Form RW by Yield10 Bioscience with the SEC, indicating that their registration statement has not yet been declared effective and confirming that no securities have been sold, could lead to negative investor sentiment. This delay in the registration statement's effectiveness might be perceived as a setback for the company, potentially impacting its stock price negatively in the short term.